Conjoint and dissociated structural and functional abnormalities in first-episode drug-naive patients with major depressive disorder: A multimodal meta-analysis

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Wang, Weina ^a   Zhao, Youjin ^a   Hu, Xinyu ^a   Huang, Xiaoqi ^a   Kuang, Weihong ^a   Lui, Su ^a   Kemp, Graham J ^b   Gong, Qiyong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRAIN MAPPING; DIAGNOSTIC IMAGING; FEMALE; GRAY MATTER; HUMAN; MAJOR DEPRESSION; MALE; META ANALYSIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 85028861449     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-08944-5     Document Type: Article

References (121)

1. Wiles, N., et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: Results of the CoBalT randomised controlled trial. Lancet 381, 375-384 (2013).
2. Monkul, E. S., et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Molecular Psychiatry 12, 360-366 (2007).
3. Gong, Q., He, Y. Depression, neuroimaging and connectomics: A selective overview. Biological Psychiatry 77, 223-235 (2015).
4. Pearlson, G. D., Calhoun, V. Structural and functional magnetic resonance imaging in psychiatric disorders. Canadian journal of psychiatry 52, 158-166 (2007).
5. Ashburner, J., Friston, K. J. Voxel-based morphometry-the methods. NeuroImage 11, 805-821 (2000).
6. Salvadore, G., et al. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. NeuroImage 54, 2643-2651 (2011).
7. Bremner, J. D., et al. Reduced volume of orbitofrontal cortex in major depression. Biological Psychiatry 51, 273-279 (2002).
8. Scheuerecker, J., et al. Orbitofrontal volume reductions during emotion recognition in patients with major depression. Journal of Psychiatry, Neuroscience 35, 311-320 (2010).
9. Frodl, T. S., et al. Depression-related variation in brain morphology over 3 years: Effects of stress? Archives of General Psychiatry 65, 1156-1165 (2008).
10. Price, J. L., Drevets, W. C. Neurocircuitry of mood disorders. Neuropsychopharmacology 35, 192-216 (2010).
11. Zou, K., et al. Changes of brain morphometry in first-episode, drug-naive, non-late-life adult patients with major depression: An optimized voxel-based morphometry study. Biological Psychiatry 67, 186-188 (2010).
12. Frodl, T., et al. Hippocampal changes in patients with a first episode of major depression. The American Journal of Psychiatry 159, 1112-1118 (2002).
13. Peng, J., et al. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: A voxel-based morphometry study. European Journal of Radiology 80, 395-399 (2011).
14. Baillieux, H., De Smet, H. J., Paquier, P. F., De Deyn, P. P., Marien, P. Cerebellar neurocognition: Insights into the bottom of the brain. Clinical Neurology and Neurosurgery 110, 763-773 (2008).
15. Dichter, G. S., Felder, J. N., Bodfish, J. W., Sikich, L., Belger, A. Mapping social target detection with functional magnetic resonance imaging. Social Cognitive and Affective Neuroscience 4, 59-69 (2009).
16. Raichle, M. E. Neuroscience. The brain's dark energy. Science 314, 1249-1250 (2006).
17. Fox, M. D., Raichle, M. E. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nature Reviews Neuroscience 8, 700-711 (2007).
18. Raichle, M. E., Mintun, M. A. Brain work and brain imaging. Annual Review of Neuroscience 29, 449-476 (2006).
19. Drevets, W. C., Price, J. L., Furey, M. L. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Structure, Function 213, 93-118 (2008).
20. Zang, Y. F., et al. Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain, Development 29, 83-91 (2007).
21. Lu, H., et al. Synchronized delta oscillations correlate with the resting-state functional MRI signal. Proceedings of the National Academy of Sciences of the United States of America 104, 18265-18269 (2007).
22. Zhu, C. Z., et al. Discriminative analysis of brain function at resting-state for attention-deficit/hyperactivity disorder. Medical Image Computing and Computer-Assisted Intervention 8, 468-475 (2005).
23. Biswal, B., Yetkin, F. Z., Haughton, V. M., Hyde, J. S. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magnetic Resonance in Medicine 34, 537-541 (1995).
24. Lu, D., et al. Altered baseline brain activity in children with bipolar disorder during mania state: A resting-state study. Neuropsychiatric Disease and Treatment 10, 317-323 (2014).
25. Takeuchi, H., et al. Regional homogeneity, resting-state functional connectivity and amplitude of low frequency fluctuation associated with creativity measured by divergent thinking in a sex-specific manner. NeuroImage 152, 258-269 (2017).
26. Wang, L., Hermens, D. F., Hickie, I. B., Lagopoulos, J. A systematic review of resting-state functional-MRI studies in major depression. Journal of Affective Disorders 142, 6-12 (2012).
27. Liu, J., et al. Alterations in amplitude of low frequency fluctuation in treatment-naive major depressive disorder measured with resting-state fMRI. Human Brain Mapping 35, 4979-4988 (2014).
28. Du, L., et al. Early life stress affects limited regional brain activity in depression. Scientific Reports 6, 25338 (2016).
29. Wang, L., et al. Frequency-dependent changes in amplitude of low-frequency oscillations in depression: A resting-state fMRI study. Neuroscience Letters 614, 105-111 (2016).
30. Wang, L., et al. Amplitude of low-frequency oscillations in first-episode, treatment-naive patients with major depressive disorder: A resting-state functional MRI study. PLoS ONE 7, e48658 (2012).
31. Zhang, X., et al. Imbalanced spontaneous brain activity in orbitofrontal-insular circuits in individuals with cognitive vulnerability to depression. Journal of Affective Disorders 198, 56-63 (2016).
32. Guo, W. B., et al. Reversal alterations of amplitude of low-frequency fluctuations in early and late onset, first-episode, drug-naive depression. Progress in Neuro-psychopharmacology, Biological Psychiatry 40, 153-159 (2013).
33. Wang, L. J., Kuang, W. H., Xu, J. J., Lei, D., Yang, Y. C. Resting-state brain activation correlates with short-time antidepressant treatment outcome in drug-naive patients with major depressive disorder. The Journal of International Medical Research 42, 966-975 (2014).
34. Guo, W. B., et al. Alterations of the amplitude of low-frequency fluctuations in treatment-resistant and treatment-response depression: A resting-state fMRI study. Progress in Neuro-psychopharmacology, Biological Psychiatry 37, 153-160 (2012).
35. Zhu, Z., et al. Spatial patterns of intrinsic neural activity in depressed patients with vascular risk factors as revealed by the amplitude of low-frequency fluctuation. Brain Research 1483, 82-88 (2012).
36. Zhang, X., et al. First-episode medication-naive major depressive disorder is associated with altered resting brain function in the affective network. PLoS ONE 9, e85241 (2014).
37. Schmidt, A. F., et al. Exploring interaction effects in small samples increases rates of false-positive and false-negative findings: Results from a systematic review and simulation study. Journal of Clinical Epidemiology 67, 821-829 (2014).
38. de Kwaasteniet, B., et al. Relation between structural and functional connectivity in major depressive disorder. Biological Psychiatry 74, 40-47 (2013).
39. Guo, W., et al. Functional and anatomical brain deficits in drug-naive major depressive disorder. Progress in Neuropsychopharmacology, Biological Psychiatry 54, 1-6 (2014).
40. Duman, R. S., Monteggia, L. M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59, 1116-1127 (2006).
41. Bessa, J. M., et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Molecular Psychiatry 14, 764-773, 739 (2009).
42. Sheline, Y. I., Gado, M. H., Kraemer, H. C. Untreated depression and hippocampal volume loss. The American Journal of Psychiatry 160, 1516-1518 (2003).
43. Lavretsky, H., Roybal, D. J., Ballmaier, M., Toga, A. W., Kumar, A. Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. The Journal of Clinical Psychiatry 66, 964-967 (2005).
44. Sheline, Y. I., et al. Treatment course with antidepressant therapy in late-life depression. The American Journal of Psychiatry 169, 1185-1193 (2012).
45. Cousins, D. A., Aribisala, B., Nicol Ferrier, I., Blamire, A. M. Lithium, gray matter, and magnetic resonance imaging signal. Biological Psychiatry 73, 652-657 (2013).
46. Vernon, A. C., et al. Contrasting effects of haloperidol and lithium on rodent brain structure: A magnetic resonance imaging study with postmortem confirmation. Biological Psychiatry 71, 855-863 (2012).
47. Frodl, T., et al. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biological Psychiatry 53, 338-344 (2003).
48. MacQueen, G. M., et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences of the United States of America 100, 1387-1392 (2003).
49. Radua, J., et al. Anisotropic kernels for coordinate-based meta-analyses of neuroimaging studies. Frontiers in Psychiatry 5, 13 (2014).
50. Radua, J., et al. A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. European Psychiatry 27, 605-611 (2012).
51. Zhong, J., Pan, P., Dai, Z., Shi, H. Voxelwise meta-analysis of gray matter abnormalities in dementia with Lewy bodies. European Journal of Radiology 83, 1870-1874 (2014).
52. Lim, L., Radua, J., Rubia, K. Gray matter abnormalities in childhood maltreatment: A voxel-wise meta-analysis. The American Journal of Psychiatry 171, 854-863 (2014).
53. Xiao, P., et al. Regional gray matter deficits in alcohol dependence: A meta-analysis of voxel-based morphometry studies. Drug and Alcohol Dependence 153, 22-28 (2015).
54. Dai, Z., et al. Gray matter correlates of migraine and gender effect: A meta-analysis of voxel-based morphometry studies. Neuroscience 299, 88-96 (2015).
55. Radua, J., Romeo, M., Mataix-Cols, D., Fusar-Poli, P. A general approach for combining voxel-based meta-analyses conducted in different neuroimaging modalities. Current Medicinal Chemistry 20, 462-466 (2013).
56. Cooper, D., Barker, V., Radua, J., Fusar-Poli, P., Lawrie, S. M. Multimodal voxel-based meta-analysis of structural and functional magnetic resonance imaging studies in those at elevated genetic risk of developing schizophrenia. Psychiatry Research 221, 69-77 (2014).
57. Radua, J., et al. Multimodal voxel-based meta-analysis of white matter abnormalities in obsessive-compulsive disorder. Neuropsychopharmacology 39, 1547-1557 (2014).
58. Zhao, Y. J., et al. Brain grey matter abnormalities in medication-free patients with major depressive disorder: A meta-analysis. Psychological Medicine 44, 2927-2937 (2014).
59. Lai, C. H., Wu, Y. T. The patterns of fractional amplitude of low-frequency fluctuations in depression patients: The dissociation between temporal regions and fronto-parietal regions. Journal of Affective Disorders 175, 441-445 (2015).
60. Cheng, Y. Q., et al. Brain volume alteration and the correlations with the clinical characteristics in drug-naive first-episode MDD patients: A voxel-based morphometry study. Neuroscience Letters 480, 30-34 (2010).
61. Tang, Y., et al. Reduced ventral anterior cingulate and amygdala volumes in medication-naive females with major depressive disorder: A voxel-based morphometric magnetic resonance imaging study. Psychiatry Research 156, 83-86 (2007).
62. Watanabe, K., et al. Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis. Psychiatry Research 233, 481-487 (2015).
63. Liu, F., et al. Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. PLoS ONE 7, e40968 (2012).
64. Tang, Y., Wu, F., Kong, L., Xu, K. Gray matter volume changes in first-episode, medication naive patients with major depressive disorder: A voxel-based morphometric 3. 0 T MRI study. Chinese Journal of Clinicians (Electronic Edition) 5, 2926-2929 (2011).
65. Xu, C., B., Y. fMRI study on the spontaneous activity of the brain in primary depression patients and their immediate family members. Journal of Practical Medical Imaging (2010).
66. Yan, R., Yao, Z., Wei, M., Tang, H., Lu, Q. Amplitude of low frequency fluctuation in female depression patients: A resting-state functional magnetic resonance imaging study. Chinese Journal of Psychiatry 47, 195-199 (2014).
67. Zhang, X., Yao, S., Zhu, X., Wang, X., Zhong, M. Gray matter volume abnormalities in individuals with cognitive vulnerability to depression: A voxel-based morphometry study. Journal of Affective Disorders 136, 443-452 (2012).
68. Kong, L., et al. Frontal-subcortical volumetric deficits in single episode, medication-naive depressed patients and the effects of 8 weeks fluoxetine treatment: A VBM-DARTEL study. PLoS ONE 9, e79055 (2014).
69. Ide, S., et al. Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI. Psychiatry Research 233, 120-124 (2015).
70. Alexander, G. E., DeLong, M. R., Strick, P. L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 9, 357-381 (1986).
71. Lu, Y., et al. The volumetric and shape changes of the putamen and thalamus in first episode, untreated major depressive disorder. NeuroImage 11, 658-666 (2016).
72. Seeley, W. W., et al. Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control. The Journal of Neuroscience 27, 2349-2356 (2007).
73. Cotter, D., et al. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex 12, 386-394 (2002).
74. Rajkowska, G., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45, 1085-1098 (1999).
75. Matsuo, K., et al. Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder. Molecular Psychiatry 12, 158-166 (2007).
76. Phan, K. L., et al. Neural substrates for voluntary suppression of negative affect: A functional magnetic resonance imaging study. Biological Psychiatry 57, 210-219 (2005).
77. George, M. S., et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biological Psychiatry 48, 962-970 (2000).
78. Kang, H. J., et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nature Medicine 18, 1413-1417 (2012).
79. Koolschijn, P. C., van Haren, N. E., Lensvelt-Mulders, G. J., Hulshoff Pol, H. E., Kahn, R. S. Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies. Human Brain Mapping 30, 3719-3735 (2009).
80. Heller, A. S., et al. Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of frontostriatal brain activation. Proceedings of the National Academy of Sciences of the United States of America 106, 22445-22450 (2009).
81. Walther, S., et al. Frontal white matter integrity is related to psychomotor retardation in major depression. Neurobiology of Disease 47, 13-19 (2012).
82. Young, K. A., Holcomb, L. A., Yazdani, U., Hicks, P. B., German, D. C. Elevated neuron number in the limbic thalamus in major depression. The American Journal of Psychiatry 161, 1270-1277 (2004).
83. Bremner, J. D., et al. Hippocampal volume reduction in major depression. The American Journal of Psychiatry 157, 115-118 (2000).
84. Bell-McGinty, S., et al. Brain morphometric abnormalities in geriatric depression: Long-term neurobiological effects of illness duration. The American Journal of Psychiatry 159, 1424-1427 (2002).
85. Avery, J. A., et al. Major depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insula. Biological Psychiatry 76, 258-266 (2014).
86. Craig, A. D. How do you feel-now? The anterior insula and human awareness. Nature Reviews Neuroscience 10, 59-70 (2009).
87. Menon, V., Uddin, L. Q. Saliency, switching, attention and control: A network model of insula function. Brain Structure, Function 214, 655-667 (2010).
88. Surguladze, S. A., et al. Depression is associated with increased sensitivity to signals of disgust: A functional magnetic resonance imaging study. Journal of Psychiatric Research 44, 894-902 (2010).
89. Elliott, R., Dolan, R. J., Frith, C. D. Dissociable functions in the medial and lateral orbitofrontal cortex: Evidence from human neuroimaging studies. Cerebral Cortex 10, 308-317 (2000).
90. Nakagawa, S., Cuthill, I. C. Effect size, confidence interval and statistical significance: A practical guide for biologists. Biological Reviews of the Cambridge Philosophical Society 82, 591-605 (2007).
91. Shepherd, A. M., Matheson, S. L., Laurens, K. R., Carr, V. J., Green, M. J. Systematic meta-analysis of insula volume in schizophrenia. Biological Psychiatry 72, 775-784 (2012).
92. Setiawan, E., et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72, 268-275 (2015).
93. Pavuluri, M. N., Passarotti, A. M., Fitzgerald, J. M., Wegbreit, E., Sweeney, J. A. Risperidone and divalproex differentially engage the fronto-striatooral circuitry in pediatric mania: A pharmacological functional magnetic resonance imaging study. Journal of the American Academy of Child and Adolescent Psychiatry 51, 157-170. e155 (2012).
94. Ramezani, M., et al. Temporal-lobe morphology differs between healthy adolescents and those with early-onset of depression. NeuroImage 6, 145-155 (2014).
95. van Eijndhoven, P., et al. Paralimbic cortical thickness in first-episode depression: Evidence for trait-related differences in mood regulation. The American Journal of Psychiatry 170, 1477-1486 (2013).
96. Takahashi, T., et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Archives of General Psychiatry 66, 366-376 (2009).
97. Schmaal, L., et al. Subcortical brain alterations in major depressive disorder: Findings from the ENIGMA Major Depressive Disorder working group. Molecular Psychiatry 21, 806-812 (2016).
98. Price, J. L. Definition of the orbital cortex in relation to specific connections with limbic and visceral structures and other cortical regions. Annals of the New York Academy of Sciences 1121, 54-71 (2007).
99. Murray, E. A., Izquierdo, A. Orbitofrontal cortex and amygdala contributions to affect and action in primates. Annals of the New York Academy of Sciences 1121, 273-296 (2007).
100. Kringelbach, M. L. The human orbitofrontal cortex: Linking reward to hedonic experience. Nature Reviews Neuroscience 6, 691-702 (2005).
101. Schoenbaum, G., Takahashi, Y., Liu, T. L., McDannald, M. A. Does the orbitofrontal cortex signal value? Annals of the New York Academy of Sciences 1239, 87-99 (2011).
102. Lacerda, A. L., et al. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biological Psychiatry 55, 353-358 (2004).
103. Adler, C. M., Levine, A. D., DelBello, M. P., Strakowski, S. M. Changes in gray matter volume in patients with bipolar disorder. Biological Psychiatry 58, 151-157 (2005).
104. Townsend, J. D., et al. fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Research 183, 209-217 (2010).
105. Drevets, W. C. Orbitofrontal cortex function and structure in depression. Annals of the New York Academy of Sciences 1121, 499-527 (2007).
106. Fu, C. H., et al. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine. BMC Psychiatry 15, 82 (2015).
107. Frodl, T., et al. Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression. Biological Psychiatry 67, 161-167 (2010).
108. Wager, T. D., Smith, E. E. Neuroimaging studies of working memory: A meta-analysis. Cognitive Affective, Behavioral Neuroscience 3, 255-274 (2003).
109. Exner, C., Lange, C., Irle, E. Impaired implicit learning and reduced pre-supplementary motor cortex size in early-onset major depression with melancholic features. Journal of Affective Disorders 119, 156-162 (2009).
110. Ottowitz, W. E., Dougherty, D. D., Savage, C. R. The neural network basis for abnormalities of attention and executive function in major depressive disorder: Implications for application of the medical disease model to psychiatric disorders. Harvard Review of Psychiatry 10, 86-99 (2002).
111. Frodl, T., et al. Different effects of mirtazapine and venlafaxine on brain activation: An open randomized controlled fMRI study. The Journal of Clinical Psychiatry 72, 448-457 (2011).
112. Liang, X., Zou, Q., He, Y., Yang, Y. Coupling of functional connectivity and regional cerebral blood flow reveals a physiological basis for network hubs of the human brain. Proceedings of the National Academy of Sciences of the United States of America 110, 1929-1934 (2013).
113. Drevets, W. C., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827 (1997).
114. Drevets, W. C., Price, J. L. Neuroimaging and neuropathological studies of mood disorders. In: Licinio JWM (ed) Biology of depression: From novel insights to therapeutic strategies. WileyVCH Verlag GmbH, Co., Weinheim, (2005).
115. Nortje, G., Stein, D. J., Radua, J., Mataix-Cols, D., Horn, N. Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder. Journal of Affective Disorders 150, 192-200 (2013).
116. Lui, S., Zhou, X. J., Sweeney, J. A., Gong, Q. Psychoradiology: The Frontier of Neuroimaging in Psychiatry. Radiology 281, 357-372 (2016).
117. Kressel, H. Y. Setting Sail: 2017. Radiology 282, 4-6 (2017).
118. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery 8, 336-341 (2010).
119. Strakowski, S. M., DelBello, M. P., Adler, C., Cecil, D. M., Sax, K. W. Neuroimaging in bipolar disorder. Bipolar Disorders 2, 148-164 (2000).
120. Radua, J., Mataix-Cols, D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. The British Journal of Psychiatry 195, 393-402 (2009).
121. Hart, H., Radua, J., Nakao, T., Mataix-Cols, D., Rubia, K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: Exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 70, 185-198 (2013).